Apixaban, empagliflozin, rivaroxaban and sacubitril/valsartan are just some of the medications included in this initial round of Medicare price negotiations. Their new prices were reduced by 56%, 66%, 62% and 53%, respectively. 

The move will save the Medicare $6 billion in just one year, an announcement from the Biden administration said.

The FDA warned that the devices failed a safety inspection, but were still distributed for patient use. They have now all been located. 

This isn't the doctor's first run in with the law. In 2019, he was arrested for his alleged involvement with a prostitution ring, though those charges were eventually dropped.

The management of stable angina has been evolving at a rapid rate. Using a one-size-fits-all strategy is becoming a thing of the past, replaced by a patient-centered approach that requires open communication and a healthy understanding of recent clinical research.

The findings are based on a survey of over 1,000 radiologists, technologists and other care providers, detailed Wednesday in JAMA Network Open. 

Such policies "shouldn’t be used as a cost-control mechanism, or as a way to delay or deny appropriate care," the health plan's CEO said. 

The Society of Nuclear Medicine and Molecular Imaging made its case in an Aug. 12 letter to the Office of Management and Budget.